- Home
- WWW vs GENB Comparison
WWW vs GENB Comparison
Compare WWW & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WWW | GENB |
|---|---|---|
| Founded | 1883 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 2003 | 2026 |
Fundamental Metrics
Financial Performance| Metric | WWW | GENB |
|---|---|---|
| Price | $22.71 | $12.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 6 |
| Target Price | $24.30 | ★ $27.00 |
| AVG Volume (30 Days) | 875.9K | ★ 901.7K |
| Earning Date | 11-12-2026 | 11-24-2026 |
| Dividend Yield | ★ 1.82% | N/A |
| EPS Growth | ★ 96.55 | N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $1,874,300,000.00 | N/A |
| Revenue This Year | $6.78 | N/A |
| Revenue Next Year | $5.83 | N/A |
| P/E Ratio | $35.87 | ★ N/A |
| Revenue Growth | ★ 6.80 | N/A |
| 52 Week Low | $14.00 | $11.00 |
| 52 Week High | $23.84 | $22.67 |
Technical Indicators
Market Signals| Indicator | WWW | GENB |
|---|---|---|
| Relative Strength Index (RSI) | 62.88 | 43.75 |
| Support Level | $15.71 | $11.93 |
| Resistance Level | $23.84 | $14.29 |
| Average True Range (ATR) | 1.09 | 1.16 |
| MACD | 0.12 | 0.00 |
| Stochastic Oscillator | 74.50 | 21.77 |
Price Performance
Historical ComparisonAbout WWW Wolverine World Wide Inc.
Wolverine World Wide Inc is engaged in designing, manufacturing, sourcing, marketing, licensing, and distributing branded footwear, apparel, and accessories. The company's segment includes Active Group; and Work Group. It generates maximum revenue from the Active Group segment. Active Group segment consists of Merrell footwear and apparel, Saucony footwear and apparel, Sweaty Betty activewear, and Chaco footwear. Geographically, the company operates in United States; Europe, Middle East and Africa; Asia Pacific; Canada; and Latin America.
About GENB Generate Biomedicines Inc. Common Stock
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.